Crinetics Pharmaceuticals, Inc. Depreciation
Crinetics Pharmaceuticals, Inc. (CRNX) reported Depreciation of $2.80 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-02-27
- Crinetics Pharmaceuticals, Inc. depreciation for fiscal 2024 was $2.80M, a 154.55% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. depreciation for fiscal 2023 was $1.10M, a 10.00% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. depreciation for fiscal 2022 was $1.00M, a 11.11% increase from fiscal 2021.
- Crinetics Pharmaceuticals, Inc. depreciation for fiscal 2021 was $900.00K, a 0.00% change from fiscal 2020.
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $2.80M 10-K · filed 2025-02-27 |
| 2023-12-31 | $1.10M 10-K · filed 2025-02-27 |
| 2022-12-31 | $1.00M 10-K · filed 2025-02-27 |
| 2021-12-31 | $900.00K 10-K · filed 2024-02-28 |
| 2020-12-31 | $900.00K 10-K · filed 2023-02-28 |
| 2019-12-31 | $900.00K 10-K · filed 2022-03-30 |
| 2018-12-31 | $500.00K 10-K · filed 2021-03-30 |